XRTX - Total Utang marang Modal XORTX Corp
XORTX Therapeutics Inc. (XRTX) focuses its biotech business on advancing its primary renal drug, limiting its scope to basic interactions with contract manufacturing organizations. The available price action vector based on the total debt-to-equity ratio is 0.00. XORTX Therapeutics Inc. (XRTX) is building a closed scientific environment for precision therapy of immune failures via proprietary xanthine oxidase inhibitors, while its resilience relies on the development of targeted agents in Canadian centers.
%20-%20Rasio%20Kabeh%20Utang%20marang%20Dana%20Pribadi&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_XRTX_-_XORTX-Therapeutics-Inc._-_All-Debt-to-Shareholders-Equity-Ratio "XRTX (XORTX Therapeutics Inc.) riwayat Total Utang marang Modal saka 04.07.2022 nganti 01.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan XORTX Therapeutics Inc.
- rega lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas XORTX Therapeutics Inc.|XRTX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal XORTX Therapeutics Inc.|XRTX - Gunggung utang perusahaan|Utang marang nilai buku XORTX Therapeutics|XRTX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan XORTX Therapeutics|Likuiditas cepet xortx.com
- informasi bathi lan kelipatan valuasi:
Analisis dhasar perusahaan:XORTX Therapeutics
XORTX Therapeutics Inc. specializes in developing long-term therapies for chronic kidney diseases, which requires significant R&D capital expenditures. By analyzing the debt-to-equity ratio, an investor assesses the proportion of borrowed funds relative to equity, which helps determine bankruptcy risk amid rising interest rates and identify potential value traps in the fundamental valuation of the business.
Analisis pesaing XORTX Therapeutics Inc.
Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA: Rasio Total Utang marang Ekuitas|SVRA (Savara Pharma) - Rasio Utang marang Ekuitas|Rigel Pharmaceuticals (RIGL) - Utang marang Ekuitas|Utang marang Modal anaptysbio.com (ANAB)|Utang marang Ekuitas Astria Therapeutics, Inc.|ENGN: Rasio Kabeh Utang marang Dana Pribadi|Rasio Total Utang marang Ekuitas RAPT (RAPT Therapeutics, Inc.)|Utang Agregat marang Modal JBIO|Aclaris Therapeutics - Rasio Total Utang marang Ekuitas|KYTX: Rasio Utang marang Ekuitas|TLSA: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi CABA (Cabaletta Bio Inc.)|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|THTX: Utang Agregat marang Modal|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|ELDN: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AGEN|CLYM - Utang marang Modal|Utang marang Ekuitas Zura Bio Limited ZURA|Rasio Kabeh Utang marang Dana Pribadi ATYR|Adagene Corp - Total Utang marang Modal|IMA - Total Utang marang Modal|shattucklabs.com (STTK) - Utang marang Ekuitas|Utang Agregat marang Ekuitas EQ (Equillium)|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Utang marang Modal Immunic Inc IMUX|Rasio Total Utang marang Ekuitas ATRA (Atara Biotherapeutics)|Total Utang marang Modal inflarx.de (IFRX)|X4 Pharmaceuticals, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal ACET (Adicet Bio Inc.)|Celularity Corp - Total Utang marang Modal|Koefisien Total Utang marang Modal INmune Bio Corporation INMB|BRNS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas kezarlifesciences.com|Utang marang Ekuitas SAB Biotherapeutics, Inc.|Akari Therapeutics PLC (AKTX) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|Koefisien Total Utang marang Modal edesabiotech.com (EDSA)|IBIO - Utang marang Ekuitas|CARM (Carisma Therapeutics) - Rasio Utang marang Ekuitas|XTLB: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Bolt Biotherapeutics, Inc.|Rasio Total Utang marang Ekuitas HCWB|Aptevo (APVO) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas AIM (AIM ImmunoTech)|aditxt.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas GRI Bio Corp GRI|Rasio Kabeh Utang marang Dana Pribadi HIND|REVB: Rasio Total Utang marang Ekuitas|indaptusrx.com - Utang Agregat marang Modal|SCNI (Scinai Immunotherapeutics Ltd.) - Rasio Total Utang marang Ekuitas|Rasio Utang marang Ekuitas CALI|Utang marang Ekuitas Affimed NV|Allakos Therapeutics - Utang Agregat marang Ekuitas|Total Utang marang Modal HOOK|IGMS (igmbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ITOS (iTeos Therapeutics, Inc.)|Total Utang marang Modal Ocean Biomedical Inc OCEA|TCBP - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)